Sexton Biotechnologies is a company focused on the development and sales of bioproduction tools for cell and gene therapy founded in 2019, located in Indianapolis, IN. Sexton develops purpose-built CGT tools and media to enable flexible automation and scaling of cell manufacturing processes to increase the probability of positive clinical outcomes and reduce time-to-market, failure points, and labor costs. Sexton's portfolio includes the CellSeal platform of cryo-storage tools and fill/finish systems along with human platelet lysate growth supplements.